NPI 0052

NPI 0052

CAS号:437742-34-2
英文名:salinosporamide A
若想填写更详细的询价信息,请点击进入询价页面
点我
化合物简介
Salinosporamide A is a potent proteasome inhibitor being studied as a potential anticancer agent. It entered phase I human clinical trials for the treatment of multiple myeloma, only three years after its discovery in 2003. This marine natural product is produced by the obligate marine bacteria Salinispora tropica and Salinispora arenicola, which are found in ocean sediment. Salinosporamide A belongs to a family of compounds, known collectively as salinosporamides, which possess a densely functionalized γ-lactam-β-lactone bicyclic core.
基本信息
编号系统
物化性质
上游原料
(2R,3aR,6S,8aS,8bS)-2-(benzyloxy)-6-(tert-butyl)-8b-methyl-4-oxotetrahydro-4H,6H-furo[2',3':3,4]pyrrolo[1,2-c]oxazole-8a(8H)-carbaldehyde (3aR,6R,6aS)-6-((S)-(S)-Cyclohex-2-enyl-hydroxy-methyl)-2-hydroxy-6a-methyl-4-oxo-hexahydro-furo[2,3-c]pyrrole-6-carboxylic acid tert-butyl ester (2R,3S,4R)-2-[(S)-{(S)-cyclohex-2-enyl}hydroxymethyl]-3-hydroxy-4-(2-hydroxyethyl)-1-(4-methoxybenzyl)-3-methyl-5-oxopyrrolidine-2-carboxylic acid methyl ester tert-butyl (2R,3aR,6S,6aS)-2-(benzyloxy)-6-formyl-5-(4-methoxybenzyl)-6a-methyl-4-oxohexahydro-2H-furo[2,3-c]pyrrole-6-carboxylate 9-cyclohex-2-enyl-9-borabicyclo[3.3.1]nonane 6-benzyl 6-(tert-butyl) (2R,3aR,6S,6aS)-2-(benzyloxy)-5-(4-methoxybenzyl)-6a-methyl-4-oxohexahydro-6H-furo[2,3-c]pyrrole-6,6-dicarboxylate (1R,4R,5S)-4-(2-chloroethyl)-1-((1S)-cyclohex-2-en-1-yl(hydroxy)methyl)-2-(4-methoxybenzyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione (2R,3S,4R)-4-(2-(benzoyloxy)ethyl)-2-((R)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-3-hydroxy-3-methyl-5-oxopyrrolidine-2-carboxylic acid methyl (2R,3aR,6S,8aS,8bS)-2-(benzyloxy)-6-(tert-butyl)-8b-methyl-4-oxotetrahydro-4H,6H-furo[2',3':3,4]pyrrolo[1,2-c]oxazole-8a(8H)-carboxylate 2-((3R,4S,5R)-5-((R)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-4-hydroxy-5-(hydroxymethyl)-4-methyl-2-oxopyrrolidin-3-yl)ethyl benzoate (1S,3R,5R,8R)-8-benzyloxycarbonyl-7-tert-butoxycarbonyl-8-((S)-((S)-cyclohex-2-enyl)(hydroxy)methyl)-3-methoxy-1-methyl-2-oxa-7-azabicyclo[3.3.0]octane-6-one (1R,4R,5S)-1-((S)-((S)-cyclohex-2-enyl)hydroxymethyl)-4-(2-hydroxyethyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione (1S,3S,5R)-8,8-dibenzyloxycarbonyl-3-methoxy-1-methyl-2-oxa-7-azabicyclo[3.3.0]octane-6-one (3S,3aS,7aR)-3-Formyl-2-(4-methoxy-benzyl)-3a,5,5-trimethyl-1-oxo-octahydro-4-oxa-2-aza-5-sila-indene-3-carboxylic acid methyl ester (1S,3S,5R,8R)-8-benzyloxycarbonyl-7-tert-butoxycarbonyl-8-hydroxymethyl-3-methoxy-1-methyl-2-oxa-7-azabicyclo[3.3.0]octane-6-one methyl (2R,3S)-2-((benzyloxy)methyl)-3-(((bromomethyl)dimethylsilyl)oxy)-1-(4-methoxybenzyl)-3-methyl-4-methylene-5-oxopyrrolidine-2-carboxylate tert-butyl (2R,3S,4R)-2-((S)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-3-hydroxy-4-(2-hydroxyethyl)-3-methyl-5-oxopyrrolidine-2-carboxylate (3S,6R,7S,7aR)-3-(tert-butyl)-7a-((R)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-7-hydroxy-6-(2-hydroxyethyl)-7-methyltetrahydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one tert-butyl (2R,3aR,6R,6aS)-2-(benzyloxy)-6-((S)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-6a-methyl-4-oxohexahydro-2H-furo[2,3-c]pyrrole-6-carboxylate (3R,4S,5R,6R)-5-(2-(benzyloxy)ethyl)-4-hydroxy-6-methoxy-4-methyltetrahydro-2H-pyran-3-yl 4-methylbenzenesulfonate methyl (3S,6R,7S,7aS)-6-allyl-3-(tert-butyl)-7-hydroxy-7-methyl-5-oxodihydro-1H,3H-pyrrolo[1,2-c]oxazole-7a(5H)-carboxylate (2R,3aR,6S,8aS,8bS)-2-(benzyloxy)-6-(tert-butyl)-8a-(hydroxymethyl)-8b-methylhexahydro-4H,6H-furo[2',3':3,4]pyrrolo[1,2-c]oxazol-4-one (3R,4S,5R,6R)-5-(2-(benzyloxy)ethyl)-6-methoxy-4-methyltetrahydro-2H-pyran-3,4-diol (2R,3aR,6S,8aR,8bS)-2-(benzyloxy)-6-(tert-butyl)-8a-((R)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-8b-methylhexahydro-4H,6H-furo[2',3':3,4]pyrrolo[1,2-c]oxazol-4-one (2R,3S,4R)-4-(2-chloroethyl)-2-((S)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-3-hydroxy-3-methyl-5-oxopyrrolidine-2-carboxylic acid methyl (2R,3S,4R)-2-((S)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-3-hydroxy-4-(2-hydroxyethyl)-3-methyl-5-oxopyrrolidine-2-carboxylate methyl (4aR,7R,7aS)-7-(hydroxymethyl)-6-(4-methoxybenzyl)-2,2,7a-trimethyl-5-oxooctahydro-[1,2]oxasilino[5,6-c]pyrrole-7-carboxylate N-((3S,4S,5R,6R)-5-(2-(benzyloxy)ethyl)-6-methoxy-4-methyl-4-((trimethylsilyl)oxy)-3-vinyltetrahydro-2H-pyran-3-yl)-2,2,2-trichloroacetamide NPI-2076 methyl (3aR,6S,8aS,8bS)-6-(tert-butyl)-2-hydroxy-8b-methyl-4-oxotetrahydro-4H,6H-furo[2',3':3,4]pyrrolo[1,2-c]oxazole-8a(8H)-carboxylate (1R,4R,5S)-1-((R)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-4-(2-hydroxyethyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione 2-((3S,6R,7S,7aR)-3-(tert-butyl)-7a-((R)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-7-hydroxy-7-methyl-5-oxotetrahydro-1H,3H-pyrrolo[1,2-c]oxazol-6-yl)ethyl benzoate 2-((3R,4S,5R)-5-((R)-((S)-cyclohex-2-en-1-yl)((trimethylsilyl)oxy)methyl)-4-hydroxy-5-(hydroxymethyl)-4-methyl-2-oxopyrrolidin-3-yl)ethyl benzoate cyclohexa-1,3-diene methyl (4aR,7R,7aS)-7-((S)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-6-(4-methoxybenzyl)-2,2,7a-trimethyl-5-oxooctahydro-[1,2]oxasilino[5,6-c]pyrrole-7-carboxylate (1S,3S,5R,8R)-8-benzyloxycarbonyl-8-(hydroxymethyl)-3-methoxy-1-methyl-2-oxa-7-azabicyclo[3.3.0]octane-6-one tert-butyl (2R,3aR,6R,6aS)-2-(benzyloxy)-6-((S)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-5-(4-methoxybenzyl)-6a-methyl-4-oxohexahydro-2H-furo[2,3-c]pyrrole-6-carboxylate benzyl ((3S,4S,5R,6R)-5-(2-(benzyloxy)ethyl)-6-methoxy-4-methyl-4-((trimethylsilyl)oxy)-3-vinyltetrahydro-2H-pyran-3-yl)carbamate (1S,3S,5R)-3-methoxy-8,8-di(methoxycarbonyl)-1-methyl-2-oxa-7-azabicyclo[3.3.0]octane-6-one NPI-2062 (4S,5R,6R)-5-(2-(benzyloxy)ethyl)-4-hydroxy-6-methoxy-4-methyldihydro-2H-pyran-3(4H)-one (3R,5S,6R)-5-(2-(benzyloxy)ethyl)-6-methoxy-4-oxotetrahydro-2H-pyran-3-yl 4-methylbenzenesulfonate tert-butyl (2R,3aR,6R,6aS)-2-(benzyloxy)-6-(hydroxymethyl)-5-(4-methoxybenzyl)-6a-methyl-4-oxohexahydro-2H-furo[2,3-c]pyrrole-6-carboxylate 2-((3aR,6R,7R,7aS)-6-methoxy-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-7-yl)ethanol